@ModifiedDarvasBox The amazing thing about the Phase 1 clinical trials that they announced this morning was the discovery of extent of its effectiveness of the vaccine at various dose levels. This was a test of safety so the efficacy part came as a pleasant surprise. If it’s reproduced on a larger scale in Phase 2, these shares will have a lot higher to go. All my best.
  • 1